用于治疗痴呆中的激越行为的包含右美沙芬化合物和奎尼丁的药物组合物
- 专利权人:
- 阿瓦尼尔制药股份有限公司
- 发明人:
- J.西弗特
- 申请号:
- CN201910903770.X
- 公开号:
- CN110664801A
- 申请日:
- 2015.14.09
- 申请国别(地区):
- CN
- 年份:
- 2020
- 代理人:
- 摘要:
- 本发明涉及在患有痴呆(包括与阿尔茨海默症相关的痴呆)的受试者中治疗激越行为和/或攻击行为和/或相关症状的方法。该方法包括向有需要的受试者给药右美沙芬化合物或其药学上可接受的盐与奎尼丁或其药学上可接受的盐的组合。本发明在某些方面还涉及用于在患有阿尔茨海默症的受试者中治疗激越行为和/或攻击行为和/或相关症状的组合物。
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- PHARMACEUTICAL COMPOSITIONS COMPRISING A DEXTROMETHORPHAN COMPOUND AND QUINIDINE FOR TREATING AGITATION IN DEMENTIA
- Pharmaceutical compositions comprising a dextromethorphan compound and quinidine for the treatment of agitation in dementia
- PHARMACEUTICAL COMPOSITIONS COMPRISING A DEXTROMETHORPHAN COMPOUND AND QUINIDINE FOR THE TREATMENT OF AGITATION IN DEMENTIA
- PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF AGITATION IN DEMENTIA
- PHARMACEUTICAL COMPOSITIONS COMPRISING A DEXTROMETHORPHAN COMPOUND AND QUINIDINE FOR THE TREATMENT OF AGITATION IN DEMENTIA